Physician profile
James P Devney
NPI 1790788172
$5,100.40
in general payments reported to CMS, 2019-2025
12 companies · $3,028 in 2025
The $3,028 reported for 2025 was more than what 90% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.99 · 2020: $44.54 · 2022: $1,537 · 2024: $450 · 2025: $3,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,763 · Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,763.24 |
| Food and Beverage | $1,715.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,071.04 | 2024-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Relievant Medsystems, INC. | $1,537.24 | 2022 | |
| Abbott Laboratories | $272.89 | 2020-2025 | Eterna |
| Boston Scientific Corporation | $41.20 | 2020-2024 | |
| Nevro Corp. | $39.99 | 2019 | |
| Curonix LLC | $28.86 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biotronik Nro, INC. | $26.31 | 2024 | Prospera |
| Collegium Pharmaceutical, INC. | $19.40 | 2024 | Xtampza |
| Mml US, INC. | $17.58 | 2025 | Reactiv8 |
| Fidia Pharma USA INC. | $16.05 | 2025 | Hymhyn |
| Vertos Medical, INC. | $15.14 | 2024 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $14.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Devney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.